Forbes  May 8  Comment 
While much of Europe has struggled in economic doldrums, KH Lloreda, Spain’s leading household cleaning company, has seen annual revenues increase by more than 10% and has achieved a ratio of 500,000 euros per employee in revenue. These...
The Hindu Business Line  Oct 29  Comment 
Kridhan Infra (formerly known as Readymade Steel India) has bagged orders worth Rs 150 crore. Kridhan secured the orders through its subsidiary KH Foges Pte Singapore. ...
The Hindu Business Line  Sep 4  Comment 
A delegation from Kolar district, Karnataka has urged Union Steel, Mines Ministry to float global tender to re-establish Bharat Gold Mines Limited. The delegation led by Member of Parlia...
Channel News Asia  Jul 10  Comment 
A residential site at Sembawang Avenue has received only four bids. A consortium comprising FCL Tampines Court and KH Capital submitted the highest bid of about S$214 million for the 22,189.7 square metre site.
JCN Network  Nov 6  Comment 
Showa Denko (SDK) (TOKYO:4004) and KH Neochem Co., Ltd. (KHNC) have agreed to dissolve their joint venture, Japan Ethyl Acetate Co., Ltd. (JEA).
The Economic Times  Oct 15  Comment 
The Minister regretted that instead of the Ludhiana industry exporting to other countries as it had all the potential to, things were being imported.
Finance Asia  Oct 3  Comment 
US company Medtronic plans to buy China’s KangHui Medical that makes orthopaedic implants, while Chinese wind company Ralls Corp is ordered to divest its interest in a US wind farm due to national security.
Finance Asia  Oct 2  Comment 
US company Medtronic plans to buy China’s KangHui Medical that makes orthopaedic implants, while Chinese wind company Ralls Corp is ordered to divest its interest in a US wind farm due to national security.
StreetInsider.com  Sep 28  Comment 
China Hydroelectric Corporation (NYSE: CHC) 22.2% HIGHER; Shareholder Group said CHC board members John D. Kuhns, Richard H. Hochman, Shadron Lee Stastney, Anthony H. Dixon and Stephen Outerbridge were replaced with Jui Kian Lim, Moonkyung Kim,...


China Kanghui Holdings (NYSE:KH) makes and markets orthopedic implants. Their products are divided into two main categories - bone fractures and spinal disorders. The bone fracture implants includes plates, screws, and nails, while the spinal implants includes interbody cages, meshes, and spinal screws. China Kangui sells its products to third party distributors who then sell the products to the individual hospitals. The company also sponsors conferences, trade shows, and training session as a marketing tool to increase brand awareness.[1]

KH is focused in China and hopes to expand its sales as the rise in China's middle class increases demand. Currently, the Western Pacific (which includes China), which has 4.8 times the population of North America, but spends only 18% of what North Americans spend on healthcare.[2] According to Frost & Sullivan, China's orthopedic market is expected to grow by a compounded annual growth rate of 18.1%.[3]The company expects to take advantage of the rising income and medical awareness in these regions to drive sales.

The company's initial public offering of stock filed on the NYSE and went public on 11 August 2010. It was priced at $10.25, in the middle of the initial price range of $9.25-$11.25. They did raise $68M by selling 6.675M shares. The lead underwriters of the deal were Morgan Stanley (MS) and Piper Jaffray Companies (PJC) .[4]

China Kanghui recorded a 31% increase in revenue between FY 2008 to FY 2009. Net Income also rose by 25%, or RMB 60 million in 2008 to RMB 75 million in 2009. The company plans to use the proceeds of the IPO to fund new manufacturing facilities, expand their salesforce, and invest in research and development.[5]


  1. KH F-1 2010 "Prospectus Summary" pg 1
  2. DMED F-1/A 2010 "Worldwide Prevalence of Diabetes" pg 76
  3. KH F-1 2010 "Our Industry" pg 2
  4. Renaissance Capital "China Kanghui prices IPO at $10.25, midpoint of the range" 11 August 2010
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki